In this issue of Blood,Cohen Aubart et al present a large series of patients with Erdheim-Chester disease (ECD) treated with BRAF and MEK inhibitors and describe the disease trajectory in a subset of these patients after treatment withdrawal.1

中文翻译：

---

Erdheim-Chester 病：“有针对性的”革命

在本期血液杂志中，Cohen Aubart 等人介绍了一系列接受 BRAF 和 MEK 抑制剂治疗的 Erdheim-Chester 病 (ECD) 患者，并描述了这些患者在停药后的亚组疾病轨迹。 1